MAXITROL ong opht tb 3.5 g

7680315660101 CH-31566 S01CA01 11.06.1.
MAXITROL ong opht tb 3.5 g
MAXITROL ong opht tb 3.5 g
1 / 2
google

Details

Product number
3156601
CPT
-
Packaging group
3,5
Unit
g
Composition
dexamethasonum 1 mg, neomycinum 3.5 mg ut neomycini sulfas 4.6 mg, polymyxini B sulfas 6000 U.I., adeps lanae 30 mg, propylis parahydroxybenzoas 0.1 mg, E 218 0.5 mg, vaselinum album ad unguentum pro 1 g.

Articles (1)

Maxitrol, Augensalbe
Augensalbe
3,5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
19/10/2020
Professional SmPC
Français
19/10/2020
Professional SmPC
Italien
19/10/2020
Patient information leaflet
Allemand
15/10/2020
Patient information leaflet
Français
15/10/2020
Patient information leaflet
Italien
15/10/2020

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3.5 MG Substance Wirkstoff (Principe actif)
(N/A)
4.6 MG Substance WIZUS
(N/A)
6000.0 UI Substance Wirkstoff (Principe actif)
(N/A)
30.0 MG Substance HBESI
(N/A)
0.1 MG Substance HBESI
(N/A)
0.5 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 13.10
Specialties list
Yes
Generic
No
SL addition date: 15/03/1968

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
31566
Drug name
Maxitrol, Augensalbe
Galenic form
AUGS
ATC Code
S01CA01
Authorization status
Z
Dispensation category
A
First authorization
07/12/1965
Authorization expiration date
31/12/9999
IT number
11.06.1.
Domain
Human medicine
Field of application
Infizierte Augenentzündungen

Packaging details

Description (FR)
MAXITROL ong opht tb 3.5 g
Description (DE)
MAXITROL Augensalbe Tb 3.5 g
Market launch
07/12/1965
Narcotic (BTM)
No